Saved Google Search 01/05/2003 . . . courtesy of
|
Preferences Search Tips | ||||||
|
|
|
|
|
|
 |
|
|
| |||||||||||||||||||||||||||||||||||||
| Sort by relevance Sorted by date |
Some
more green stuff
Philadelphia Daily
News, PA - 20 hours ago
...
S. Broad Street. (Anxious? Stoke up on Paxil.). • Valley Green
Inn,
Forbidden Drive along Wissahickon Creek. (Feast on roast falcon.).
...
Action
Line
Miami
Herald, FL - 21 hours ago
... My mother's doctor switched the alprazolam to Paxil,
which the insurance paid
for, but I have to pay for the Exelon myself, and
it's an expensive drug. ...
The
Long Journey Back: Surviving Depression
Washington Post, DC - 23 hours
ago
... born with. He prescribed Paxil,
trying to convince himself and me
that I was suffering from social anxiety
disorder. He assured ...
Market
Miscellany
Daily
Telegraph, UK - 04 Jan 2003
... Drugs giant GlaxoSmithKline (£12.08) reckons it can fight off
attempts by rivals
to launch copycat versions of Paxil, after a US
court upheld just one of four ...
Company
News
Creditman, UK - 04 Jan 2003
... GLAXOSMITHKLINE was cheered by a pre-trial court decision in
America that it claims
will defend Paxil, its money-spinning
antidepressant, from competition by ...
Born
to Be Happy, Through a Twist of Human Hard Wire
New York Times - 03 Jan 2003
... A study by Dr. Brian Knutson at the University of California
at San Francisco
looked at the effects of the serotonin-enhancing
antidepressant Paxil among ...
GlaxoSmithKline
buys time in Paxil court case
NEPA
News, PA - 03 Jan 2003
A federal
judge in Philadelphia gave a mixed decision in litigation over British
drug
company GlaxoSmithKline PLC's patents for anti-depressant Paxil, the
...
GlaxoSmithKline
upgraded to "accumulate"
Newratings, NY - 03 Jan 2003
... in 2002. Moreover, the company lost the Augmentin patent,
while another
drug, Paxil, has been challenged, says Jyske Bank. The
analyst ...
SkyePharma
Jumps on $120 Million Deal
ABC
News - 03 Jan 2003
... for
SkyePharma have brightened since last April following the successful
launch
of a slow-release version of GlaxoSmithKline Plc's antidepressant
Paxil CR. ...
SkyePharma
Jumps on $120 Million Deal
Reuters, UK - 03 Jan 2003
... for SkyePharma have brightened since last April following the
successful launch
of a slow-release version of GlaxoSmithKline Plc's
antidepressant Paxil CR. ...
Born
to Be Happy, Through a Twist of Human Hard Wire
New York Times - 02 Jan 2003
... A study by Dr. Brian Knutson at the University of California
at San Francisco
looked at the effects of the serotonin-enhancing
antidepressant Paxil among ...
Hard-wired
for happiness
Toronto
Star, Canada - 02 Jan 2003
... A study at the University of California looked at the effects
of the serotonin-enhancing
antidepressant Paxil among normal
volunteers, assigned at random to a ...
UK
Outlook: Threat of war makes for an uncertain year ahead
Independent, UK - 02 Jan
2003
... to be dictated in the courtrooms of the
US, particularly for GSK, which is still
fighting challenges to patents on
its biggest drug, the anti-depressant Paxil ...
CORRECTED
- Banks , oils inject life into FTSE 100 , GKN gains
Forbes - 02 Jan 2003
... a drag as it eased 1.9 percent to retrace a rise earlier this
week when investors
were encouraged by a patent ruling on its top selling
anti-depressant, Paxil. ...
CORRECTED
- Banks , oils inject life into FTSE 100 , GKN gains
Reuters, UK - 02 Jan 2003
... a drag as it eased 1.9 percent to retrace a rise earlier this
week when investors
were encouraged by a patent ruling on its top selling
anti-depressant, Paxil. ...
Banks, oils
inject life into FTSE 100, GKN gains
Forbes - 02 Jan 2003
... a drag as it eased 1.9 percent to retrace a rise earlier this
week when investors
were encouraged by a patent ruling on its top selling
anti-depressant, Paxil. ...
Banks,
oils inject life into FTSE 100, GKN gains
Reuters, UK - 02 Jan 2003
... a drag as it eased 1.9 percent to retrace a rise earlier this
week when investors
were encouraged by a patent ruling on its top selling
anti-depressant, Paxil. ...
Banks
help FTSE to edge higher, though GSK falls
Reuters, UK - 02 Jan 2003
... L fell two percent, retracing some of its gain earlier in the
week when investors
were encouraged by a patent ruling on its top selling
anti-depressant, Paxil. ...
FTSE
100 starts 2003 on weak note
Financial
Times (subscription), UK - 02 Jan 2003
... Glaxo SmithKline was also hit by profit-taking after it rose
sharply on Tuesday following
positive comments about the recent patent case
related to Paxil, its ...
British
Airways leads FTSE up but GSK slips
Reuters, UK - 02 Jan 2003
... at 1170 pence, slipping back after advances earlier in the
week, when investors were
inspired by a patent ruling on its top selling
anti-depressant drug Paxil. ...
Born
to Be Happy, Through a Twist of Human Hard Wire
New York Times - 01 Jan 2003
... A study by Dr. Brian Knutson at the University of California
at San Francisco
looked at the effects of the serotonin-enhancing
antidepressant Paxil among ...
Footsie
ends dismal year on high note
Financial
Times (subscription), UK - 01 Jan 2003
... GlaxoSmithKline headed the buoyant blue chips following
positive comment on
the recent patent case related to Paxil, its
anti-depressant drug Paxil. ...
Testosterone
tested as mood drug
Boston
Globe, MA - 01 Jan 2003
...
Psychiatrists have since abandoned such treatment for newer ideas, first
electroshock
therapy and then antidepressant drugs such as Prozac and
Paxil. ...
Eurostocks
trims gains, US consumer confidence off
The Times of Malta, Malta - 01 Jan
2003
... reaffirmed its earnings guidance and a
court ruling fuelled hopes it could head
off potential rivals to one of its
top-selling drugs, anti-depressant Paxil. ...
Viagra
may ease antidepressant side effect
Newark Star Ledger, NJ - 31 Dec
2002
... that Viagra, Pfizer's impotence
treatment, can help improve the sexual function of
men taking a class of
anti-depressants that includes Prozac, Zoloft and Paxil ...
New
Year's rant: The real trouble with liberals
WorldNetDaily - 31 Dec 2002
... Liberals take Paxil and Prozac and Wellbutrin so they
can be mellow at all
times. Liberals have come to be synonymous with wusses
and wimps. ...
Born
to Be Happy, Through a Twist of Human Hard Wire
New York Times - 31 Dec 2002
... A study by Dr. Brian Knutson at the University of California
at San Francisco
looked at the effects of the serotonin-enhancing
antidepressant Paxil among ...
Market
forces
Guardian, UK - 31 Dec 2002
... continued a recovery with a 3.9% rise as traders digested the
implications of the
substantial court victory to protect its blockbuster
anti-depressant, Paxil. ...
World
stocks: Dow snaps 4-day losing streak
New
Zealand Herald, New Zealand - 31 Dec 2002
... FTSE-100 to a positive close in thin trade and pharmaceutical
giant GlaxoSmithKline
added to the cheer after a patent ruling on its
anti-depressant drug Paxil. ...
ADR
Report-Overseas shares wrap up 2002 on flat note
Forbes - 31 Dec 2002
... The group reaffirmed its earnings guidance and a court ruling
fueled hopes it
could head off potential rivals to its antidepressant
Paxil, one of its top ...
FTSE
shrugs off 2002 woes to end session on upbeat note
Reuters, UK - 31 Dec 2002
... session, when GSK repeated its earnings guidance and a court
ruling fuelled hopes
it could head off potential rivals to one of its
top-selling drugs, Paxil. ...
Dire
year ends for eurostocks, jittery 2003 looms
Forbes - 31 Dec 2002
... reaffirmed its earnings guidance and a court ruling fuelled
hopes it could head
off potential rivals to one of its top-selling drugs,
anti-depressant Paxil. ...
UPDATE: European
Stocks Close Out 2002 In Upbeat Fashion
Yahoo Headlines - 31 Dec 2002
... chewed over the implications of GlaxoSmithKline statement
Monday that it is confident
it can prevent generic competition against its
depression drug Paxil. ...
Eurostocks
Hold Gains, US Consumer Confidence Eyed
Morningstar Canada, Canada - 31 Dec
2002
... reaffirmed its earnings guidance and a
court ruling fuelled hopes it could head
off potential rivals to one of its
top-selling drugs, anti-depressant Paxil. ...
Eurostocks
Trims Gains After US Data
ABC
News - 31 Dec 2002
... group
reaffirmed its earnings guidance and a court ruling fueled hopes it could
head
off potential rivals to one of its top-selling drugs, anti-depressant
Paxil ...
Eurostocks
trims gains, US consumer confidence off
Forbes - 31 Dec 2002
... reaffirmed its earnings guidance and a court ruling fuelled
hopes it could head
off potential rivals to one of its top-selling drugs,
anti-depressant Paxil. ...
Eurostocks
Trims Gains After US Data
Reuters, UK - 31 Dec 2002
... group reaffirmed its earnings guidance and a court ruling
fueled hopes it could head
off potential rivals to one of its top-selling
drugs, anti-depressant Paxil ...
Judge
splits decision in Glaxo case
Philadelphia Business Journal, PA - 31 Dec
2002
... District Court judge in Philadelphia
rendered a split decision Monday in a patent
dispute involving
GlaxoSmithKline's top-selling drug, the antidepressant Paxil ...
Eurostocks
hold gains, US consumer confidence eyed
Forbes - 31 Dec 2002
... reaffirmed its earnings guidance and a court ruling fuelled
hopes it could head
off potential rivals to one of its top-selling drugs,
anti-depressant Paxil. ...
European Stocks Close
Out 2002 In Upbeat Fashion
Yahoo
Headlines - 31 Dec 2002
...
chewed over the implications of GlaxoSmithKline statement Monday that it is
confident
it can prevent generic competition against its depression drug
Paxil. ...
Decision
Is Mixed in Paxil Patents Case
Newsday - 31 Dec 2002
LONDON -- A federal judge gave a mixed decision in litigation over
British drug
company GlaxoSmithKline PLC's patents for anti-depressant
Paxil, the company ...
FTSE
shrugs off 2002 woes to end session on upbeat note
Forbes - 31 Dec 2002
... session, when GSK repeated its earnings guidance and a court
ruling fuelled hopes
it could head off potential rivals to one of its
top-selling drugs, Paxil. ...
FTSE
ends higher on last day of 2002; GSK strong
Forbes - 31 Dec 2002
... giant GlaxoSmithKline closed 3.9 percent up as it continued
to benefit from hopes
that it would successfully fend off rivals to its
blockbuster drug Paxil. ...
Apotex
loses Paxil court case
National
Post, Canada - 31 Dec 2002
... criticized what it called outdated drug laws after a US judge
upheld a key patent
on anti-anxiety drug Paxil, a ruling that prevents
Apotex from launching its ...
Glaxo
wins partial victory in patent battle
icWales, UK - 31 Dec 2002
DRUGS giant GlaxoSmithKline claimed a partial victory in its battle to
prevent
the launch of generic competition to its key Paxil treatment
yesterday. ...
Dow
climbs 29, Nasdaq falls 8
Baltimore
Sun, MD - 31 Dec 2002
... A
US federal judge ruled in favor of the second-largest drugmaker, which
is
seeking to fend off cheaper competitors to its $3 billion-a-year
Paxil. ...
GSK
wins a legal round
Raleigh
News, NC - 31 Dec 2002
RESEARCH
TRIANGLE PARK -- GlaxoSmithKline has scored a tactical victory against
generic
versions of its blockbuster anti-depressant Paxil, a legal
battle that ...
Meadowbrook,
Rouge lead gains
Detroit
News, MI - 30 Dec 2002
...
won US regulatory approval for its migraine medicine and one of
GlaxoSmithKline
Plc's patents for its Paxil antidepressant received
protection from a US ...
Daily
Briefing
The News
Journal, DE - 30 Dec 2002
A
federal judge gave a mixed decision in litigation over British drug
company
GlaxoSmithKline PLC's patents for anti-depressant Paxil. ...
Gannett,
Lilly, Celadon lift state equity index
Indianapolis Star, IN - 30 Dec
2002
... Philadelphia -- A federal judge gave a
mixed decision in litigation over British
drug company GlaxoSmithKline PLC's
patents for antidepressant Paxil, the ...
Apotex
gets split decision on patent
Toronto
Star, Canada - 30 Dec 2002
has
emerged with a split decision in an American patent case
against
Glaxo-SmithKline Inc. over the anti-depression drug Paxil.
...
Apotex
wins small victory against Glaxo
The
Globe and Mail, Canada - 30 Dec 2002
... won a small victory yesterday in its legal bid to sell a
generic version of the
anti-depressant drug Paxil, after a US judge
ruled against British drug giant ...
Banks
nudge TSX back into black
The Globe and
Mail, Canada - 30 Dec 2002
... won US regulatory approval for a migraine medicine and a US
judge upheld one of GlaxoSmithKline
PLC's patents for the antidepressant
Paxil, its biggest seller. ...
Born
to Be Happy, Through a Twist of Human Hard Wire
New York Times - 30 Dec 2002
... A study by Dr. Brian Knutson at the University of California
at San Francisco
looked at the effects of the serotonin-enhancing
antidepressant Paxil among ...
Decision
Is Mixed in Paxil Patents Case
Newsday - 30 Dec 2002
LONDON -- A federal judge gave a mixed decision in litigation over
British drug
company GlaxoSmithKline PLC's patents for anti-depressant
Paxil, the company ...
Decision
Is Mixed in Paxil Patents Case
Yahoo Headlines - 30 Dec 2002
LONDON - A federal judge gave a mixed decision in litigation over
British drug
company GlaxoSmithKline PLC's patents for anti-depressant
Paxil, the company ...
Decision Is
Mixed in Paxil Patents Case
ABC
News - 30 Dec 2002
A federal judge gave
a mixed decision in litigation over British drug company
GlaxoSmithKline
PLC's patents for anti-depressant Paxil, the company
said Monday. ...
PRESS
DIGEST - Wall Street Journal - Dec 31
Forbes - 30 Dec 2002
... GlaxoSmithKline said it is confident it can prevent generic
competition to its
depression drug Paxil, despite a mixed initial
verdict in its legal case ...
Glaxo
protects Paxil patent, thwarting generic rivals
Pittsburgh Tribune
Review, PA - 30 Dec 2002
LONDON —
GlaxoSmithKline Plc said a US judge upheld one of its patents for
Paxil,
helping the world's second-biggest drugmaker fend off cheaper
competitors ...
OPEC
May Increase Supplies
Washington
Post, DC - 30 Dec 2002
Pharmacist
Donald Tierney displays Paxil in his drugstore in Wilmette,
Ill.,
yesterday. A federal judge has upheld one of GlaxoSmithKline's ...
European
Markets Settle Higher in Light Trading
Quicken - 30 Dec 2002
... group GlaxoSmithKline gained 27 pence, or 2.4%, to 11.47
pounds after a US judge
ruled in the company's favor on a patent for its
best- selling drug, Paxil ...
CANADA
NEWSWIRE SUMMARY OF RELEASES FOR MONDAY, DECEMBER 30, 2002
Canada NewsWire (press
release), CA - 30 Dec 2002
... Update on Paxil Patent Litigation (PA-Update-
on-Paxil) C6771 - BASINGSTOKE, UK
: Shire sells Over The Counter (OTC)
Products Portfolio to Purdue (Shire-sells ...
Abreast Of The Mkt:
Centex, Newmont Mining Dn Mon
Yahoo
Headlines - 30 Dec 2002
...
GlaxoSmithKline climbing 89 cents, or 2.5%, to 36.81 after the British
pharmaceutical
firm expressed confidence that it can protect its depression
drug Paxil ...
Glaxo
faces losing exclusive rights to £5m-a-day blockbuster ...
Guardian, UK - 30 Dec
2002
drug Paxil after a US judge ordered a trial
to establish the validity
of three of its patents on the product. GSK has
enjoyed almost ...
World Stk Mkts:
Japanese Stks End Yr With Declines
Yahoo
Headlines - 30 Dec 2002
...
group GlaxoSmithKline gained 2.4%, or 27 pence, to GBP 11.47 after a US judge
ruled
in the company's favor on a patent for its best-selling drug,
Paxil, but ...
US
court rules a Paxil patent as invalid
Economic Times, India - 30 Dec
2002
LONDON: PHARMACEUTICAL giant GlaxoSmithKline said
on Monday that a US judge had
ruled one patent related to its top-selling
anti-depressant Paxil was invalid ...
City
Market Report
icWales, UK - 30 Dec 2002
... US. A US judge upheld one of the patents covering its
antidepressant
Paxil in a key summary judge-ment while invalidating
another. ...
Born
to Be Happy, Through a Twist of Human Hard Wire
New York Times - 30 Dec 2002
... A study by Dr. Brian Knutson at the University of California
at San Francisco
looked at the effects of the serotonin-enhancing
antidepressant Paxil among ...
Oils boost
Footsie in thin trading
The
Scotsman, UK - 30 Dec 2002
... drugs stock GlaxoSmithKline added to the improved sentiment
in the City by grabbing
a partial victory in a key patent case for its
anti-depressant drug, Paxil. ...
ADR Report -2: China's
Telecom Shares Down >CTEL CHU
Yahoo
Headlines - 30 Dec 2002
...
advanced 2.5% to $36.81 as the company assured investors its earnings wouldn't
be
hurt by a court ruling against its depression and social anxiety drug
Paxil. ...
London
shares gain in light trading, oils lead
Channel News Asia, Singapore - 30 Dec
2002
... percent to 406.25 pence. Pharmaceuticals
also firmed thanks to a positive
US court ruling for GlaxoSmithKline on its
Paxil drug.
US Late Market Comment
-5: Liberty Media Up On Sale News
Yahoo
Headlines - 30 Dec 2002
... of
GlaxoSmithKline PLC rising 89 cents, or 2.5%, to 36.81 after the
pharmaceutical
firm expressed confidence it can protect its antidepressant
drug Paxil from ...
US Late Market
Comment-4: Tyco Up Ahead Of Probe Release
Yahoo Headlines - 30 Dec 2002
... of GlaxoSmithKline PLC rising 89 cents, or 2.5%, to 36.81
after the pharmaceutical
firm expressed confidence it can protect its
antidepressant drug Paxil from ...
ADR Report: Europe
Strength Offsets LatAm, Asia Weakness
Yahoo Headlines - 30 Dec 2002
... advanced 2.5% to $36.81 as the company assured investors its
earnings wouldn't be
hurt by a court ruling against its depression and social
anxiety drug Paxil. ...
Split
decision from court in Paxil patent case
CTV, Canada - 30 Dec 2002
... Inc. has emerged with a split decision in an American patent
case
against GlaxoSmithKline over the antidepression drug Paxil. A
...
Glaxo
loses one Paxil patent; another upheld
Business Times, Singapore - 30 Dec
2002
GLAXOSMITHKLINE Plc said a US federal judge
invalidated one patent for the anti-depressant
Paxil and supported
another as the world's second-largest drugmaker ...
European Markets
Settle Higher in Light Trading
Yahoo
Headlines - 30 Dec 2002
...
group GlaxoSmithKline gained 27 pence, or 2.4%, to 11.47 pounds after a US
judge
ruled in the company's favor on a patent for its best-selling drug,
Paxil, but ...
European
Markets Settle Higher in Light Trading
Quicken - 30 Dec 2002
... group GlaxoSmithKline gained 27 pence, or 2.4%, to 11.47
pounds after a US judge
ruled in the company's favor on a patent for its
best- selling drug, Paxil ...
US court offers
split decision in Apotex-Glaxo patent tangle over ...
Waterloo Record, Canada - 30 Dec
2002
... Inc. has emerged with a split decision
in an American patent case
against GlaxoSmithKline over the antidepression
drug Paxil. A ...
Lex:
Patently happy
Financial Times
(subscription), UK - 30 Dec 2002
Where Prozac failed, will another happy pill, Paxil, dispel the
gloom
over the pharmaceuticals sector? It may be too early to share
...
Markets
move higher
The
Australian, Australia - 30 Dec 2002
... Shares in British drugs giants GlaxoSmithKline firmed 2.41
per cent to 1147 pence
after providing an update on litigation over its
patent on the Paxil/Seroxat ...
Markets
move higher
News
Interactive, Australia - 30 Dec 2002
... Shares in British drugs giants GlaxoSmithKline firmed 2.41
per cent to 1147 pence
after providing an update on litigation over its
patent on the Paxil/Seroxat ...
US
court offers split decision in Apotex-Glaxo patent tangle over ...
Ottawa
Citizen, Canada - 30 Dec 2002
... Inc. has emerged with a split decision in an American patent
case
against GlaxoSmithKline over the antidepression drug Paxil. A
...
US
court offers split decision in Apotex-Glaxo patent tangle over ...
Canada.com, Canada - 30 Dec
2002
... Inc. has emerged with a split decision
in an American patent case
against GlaxoSmithKline over the antidepression
drug Paxil. A ...
US
court offers split decision in Apotex-Glaxo patent tangle over ...
St. Catharines
Standard, Canada - 30 Dec 2002
... Inc. has emerged with a split decision in an American patent
case
against GlaxoSmithKline over the antidepression drug Paxil. A
...
US court offers
split decision in Apotex-Glaxo patent tangle over ...
CBC News, Canada - 30 Dec
2002
... Inc. has emerged with a split decision
in an American patent case
against GlaxoSmithKline over the antidepression
drug Paxil. A ...
Apotex, Glaxo
legal fight over Paxil continues
CBC News, Canada - 30 Dec 2002
TORONTO - Apotex Inc.'s legal battle with GlaxoSmith Kline over the
patents on the
anti-depression drug Paxil continued as a Philadelphia
judge issued split ...
GlaxoSmithKline
buys time in Paxil court case
Penn
Live, PA - 30 Dec 2002
...
AP) -- A federal judge in Philadelphia gave a mixed decision in litigation
over
British drug company GlaxoSmithKline PLC's patents for anti-depressant
Paxil ...
Glaxo gets
split verdict
CNN/Money - 30 Dec 2002
Europe's biggest drugmaker said a US judge had ruled in its favor on one
patent related
to its anti-depressant drug Paxil, but had also
decided, in the summary ...
GlaxoSmithKline
buys time in Paxil court case
Boston.com, MA - 30 Dec 2002
LONDON (Dow Jones/AP) A federal judge gave a mixed decision in
litigation over
British drug company GlaxoSmithKline PLC's patents for
anti-depressant Paxil ...
GlaxoSmithKline
buys time in Paxil court case
Miami Herald, FL - 30 Dec 2002
LONDON - A federal judge in Philadelphia gave a mixed decision in
litigation over
British drug company GlaxoSmithKline PLC's patents for
anti-depressant Paxil ...
Mixed
Decision in GlaxoSmithKline Case
Newsday - 30 Dec 2002
LONDON -- A federal judge gave a mixed decision in litigation over
British drug
company GlaxoSmithKline PLC's patents for anti-depressant
Paxil, the company ...
Mixed
Decision in GlaxoSmithKline Case
Sarasota
Herald-Tribune, FL - 30 Dec 2002
A
federal judge gave a mixed decision in litigation over British drug company
GlaxoSmithKline
PLC's patents for anti-depressant Paxil, the company
said Monday. ...
Mixed
Decision in GlaxoSmithKline Case
Austin
American Statesman, TX - 30 Dec 2002
LONDON (AP)--A federal judge gave a mixed decision in litigation over
British drug
company GlaxoSmithKline PLC's patents for anti-depressant
Paxil, the company ...
Mixed
Decision in GlaxoSmithKline Case
ABC
News - 30 Dec 2002
A federal judge gave
a mixed decision in litigation over British drug company
GlaxoSmithKline
PLC's patents for anti-depressant Paxil, the company
said Monday. ...
Mixed
Decision in GlaxoSmithKline Case
Lakeland
Ledger, FL - 30 Dec 2002
A federal
judge gave a mixed decision in litigation over British drug company
GlaxoSmithKline
PLC's patents for anti-depressant Paxil, the company
said Monday. ...
Mixed
Decision in GlaxoSmithKline Case
Times
Daily, AL - 30 Dec 2002
A federal
judge gave a mixed decision in litigation over British drug company
GlaxoSmithKline
PLC's patents for anti-depressant Paxil, the company
said Monday. ...
Mixed
Decision in GlaxoSmithKline Case
Miami
Herald, FL - 30 Dec 2002
LONDON -
A federal judge gave a mixed decision in litigation over British drug
company
GlaxoSmithKline PLC's patents for anti-depressant Paxil, the company
...
Mixed
Decision in GlaxoSmithKline Case
Seattle
Post Intelligencer, WA - 30 Dec 2002
LONDON -- A federal judge gave a mixed decision in litigation over
British drug
company GlaxoSmithKline PLC's patents for anti-depressant
Paxil, the company ...
|
| Google Home - Advertise with Us - Search Solutions - Services & Tools - Jobs, Press, & Help |
